Foothill Scientific Associates — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Foothill Scientific Associates (FSA) is a specialized consulting firm founded in 2019 that provides expert guidance to life science companies, primarily in securing non-dilutive government funding and executing lean business operations. The firm leverages deep industry and US government program experience, claiming a 90% win rate and over $1 billion in program awards secured for clients since its inception. Its service model is designed to be agile and scalable, offering partner-level expertise at associate-level rates to help early-stage innovators advance their technologies from development to commercialization. FSA positions itself as a seasoned guide for navigating the high-stakes, complex environments of federal grants and life science venture building.

DiagnosticsMedical Devices

Technology Platform

Consulting firm with a knowledge-based platform for securing non-dilutive government funding and providing integrated business and technical operations support for life science companies.

Opportunities

The growing complexity and competition for US government non-dilutive funding creates sustained demand for specialized guidance.

The trend toward lean, virtual biotech companies increases the need for fractional, high-level operational expertise.

Geographic expansion into Europe (Ireland office planned for 2026) opens access to new client bases and EU funding mechanisms.

Risk Factors

Revenue is tied to the cyclical health of the early-stage biotech sector and subject to shifts in US federal funding priorities and budgets.

The business model is highly reputation-dependent and faces competition from other consultants and firms.

Scaling the people-intensive service model while maintaining quality and its high win-rate claim presents an operational challenge.

Competitive Landscape

FSA competes in a fragmented market including solo consultants, boutique life science consulting firms, and broader management consulting firms with healthcare practices. Differentiation is based on claimed seniority of expertise, specific success rates in government funding, and a cost-flexible model tailored for startups. Larger CROs and strategic consulting firms may also overlap in technical operations and business strategy services.

More companies in Digital Health & Biotech SaaS →More companies in United States →